Christopher August Lucchesi
|
|
| Title(s) | Assistant Adjunct Professor, MED: Urologic Surgery |
|---|
| School | School of Medicine |
|---|
| vCard | Download vCard |
|---|
|
|
Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
ANGEL2 modulates wildtype TP53 translation and doxorubicin chemosensitivity in colon cancer. Mol Cancer Res. 2025 Mar 07.
Lucchesi CA, Mantrala S, Tran D, Batra N, Durve A, Suen C, Zhang J, Ghosh P, Chen X. PMID: 40052999.
View in:
PubMed Mentions: Fields:
-
Alterations in Tumor Aggression Following Androgen Receptor Signaling Restoration in Canine Prostate Cancer Cell Lines. Int J Mol Sci. 2024 Aug 07; 25(16).
Vasilatis DM, Batra N, Lucchesi CA, Abria CJ, Packeiser EM, Murua Escobar H, Ghosh PM. PMID: 39201315; PMCID: PMC11354774.
View in:
PubMed Mentions: Fields:
Translation:
AnimalsCells
-
Ninjurin 2, a Cell Adhesion Molecule and a Target of p53, Modulates Wild-Type p53 in Growth Suppression and Mutant p53 in Growth Promotion. Cancers (Basel). 2024 Jan 04; 16(1).
Zhang J, Kong X, Yang HJ, Mohibi S, Lucchesi CA, Zhang W, Chen X. PMID: 38201656; PMCID: PMC10778559.
View in:
PubMed Mentions:
1
-
Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies. Int J Mol Sci. 2023 Jul 13; 24(14).
Lucchesi CA, Vasilatis DM, Mantrala S, Chandrasekar T, Mudryj M, Ghosh PM. PMID: 37511154; PMCID: PMC10380322.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansAnimals
-
Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer. Sci Rep. 2023 06 14; 13(1):9617.
Steele TM, Tsamouri MM, Siddiqui S, Lucchesi CA, Vasilatis D, Mooso BA, Durbin-Johnson BP, Ma AH, Hejazi N, Parikh M, Mudryj M, Pan CX, Ghosh PM. PMID: 37316561; PMCID: PMC10267166.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansAnimals
-
Identification of a First-in-Class Small-Molecule Inhibitor of the EIF4E-RBM38 Complex That Enhances Wild-type TP53 Protein Translation for Tumor Growth Suppression. Mol Cancer Ther. 2023 06 01; 22(6):726-736.
Lucchesi CA, Zhang J, Gao M, Shaw J, Chen X. PMID: 36940176; PMCID: PMC10866396.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansCells
-
Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants. Biomedicines. 2023 Apr 05; 11(4).
Vasilatis DM, Lucchesi CA, Ghosh PM. PMID: 37189720; PMCID: PMC10136260.
View in:
PubMed Mentions:
2
-
Microglia-Derived Olfactomedin-like 3 Is a Potent Angiogenic Factor in Primary Mouse Brain Endothelial Cells: A Novel Target for Glioblastoma. Int J Mol Sci. 2022 Nov 23; 23(23).
Joseph LM, Toedebusch RG, Debebe E, Bastian AH, Lucchesi CA, Syed-Quadri S, Wittenburg LA, Chen X, Meyers FJ, Toedebusch CM. PMID: 36498941; PMCID: PMC9741462.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansAnimalsCells
-
Optimization of eIF4E-Binding Peptide Pep8 to Disrupt the RBM38-eIF4E Complex for Induction of p53 and Tumor Suppression. Front Oncol. 2022; 12:893062.
Lucchesi CA, Zhang J, Vasilatis DM, Yip E, Chen X. PMID: 35574389; PMCID: PMC9095979.
View in:
PubMed Mentions:
1
-
Microglia-Derived Olfactomedin-like 3 Promotes Pro-Tumorigenic Microglial Function and Malignant Features of Glioma Cells. Int J Mol Sci. 2021 Dec 02; 22(23).
Toedebusch RG, Lucchesi CA, Debebe ET, Wittenburg LA, Chen X, Toedebusch CM. PMID: 34884869; PMCID: PMC8657851.
View in:
PubMed Mentions:
7 Fields:
Translation:
HumansAnimalsCells
-
Survivin Expression Is Differentially Regulated by a Selective Cross-talk between RBM38 and miRNAs let-7b or miR-203a. Cancer Res. 2021 04 01; 81(7):1827-1839.
Lucchesi CA, Zhang J, Ma B, Nussinov R, Chen X. PMID: 33472892; PMCID: PMC8137528.
View in:
PubMed Mentions:
4 Fields:
-
Measuring Translation Efficiency by RNA Immunoprecipitation of Translation Initiation Factors. Methods Mol Biol. 2021; 2267:73-79.
Lucchesi C, Mohibi S, Chen X. PMID: 33786785.
View in:
PubMed Mentions:
3 Fields:
Translation:
HumansAnimalsCells
-
Disruption of the Rbm38-eIF4E Complex with a Synthetic Peptide Pep8 Increases p53 Expression. Cancer Res. 2019 02 15; 79(4):807-818.
Lucchesi CA, Zhang J, Ma B, Chen M, Chen X. PMID: 30591552; PMCID: PMC6377842.
View in:
PubMed Mentions:
20 Fields:
-
Ninjurin 1 has two opposing functions in tumorigenesis in a p53-dependent manner. Proc Natl Acad Sci U S A. 2017 10 24; 114(43):11500-11505.
Yang HJ, Zhang J, Yan W, Cho SJ, Lucchesi C, Chen M, Huang EC, Scoumanne A, Zhang W, Chen X. PMID: 29073078; PMCID: PMC5664541.
View in:
PubMed Mentions:
29 Fields:
Translation:
HumansAnimalsCells
-
Modulation of the p53 family network by RNA-binding proteins. Transl Cancer Res. 2016 Dec; 5(6):676-684.
Lucchesi C, Zhang J, Chen X. PMID: 28794999; PMCID: PMC5546219.
View in:
PubMed Mentions:
8
-
A new function for p53 tetramerization domain in cell fate control. Cell Cycle. 2016 11; 15(21):2854-2855.
Zhang J, Lucchesi C, Chen X. PMID: 27355441; PMCID: PMC5105913.
View in:
PubMed Mentions:
1 Fields:
Translation:
Cells
This graph shows the total number of publications by year. To see the data as text,
click here.
This graph shows the total number of publications by year. To return to the graph,
click here.
| Year | Publications |
|---|
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text,
click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs